Future studies should leverage publicly available RNAseq datasets to analyze the expression dynamics of PI3K, AKT, 4EBP1, mTOR, and PTEN in primary ALL patient samples treated with decitabine. The gene discussed is PTEN; the disease is acute lymphoblastic leukemia.